Efficacy of alpha lipoic acid in burning mouth syndrome: A randomized, placebo-treatment study

Journal of Oral Rehabilitation

Volumn 36, Issue 1, 2009, Pages 52-57

  Lopez Jornet P ^a,b   Camacho Alonso, F ^a   Leon Espinosa, S ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Alpha lipoic acid; Burning mouth; Glossodynia; Placebo; Treatment

Indexed keywords

ANTIOXIDANT; THIOCTIC ACID;

AGED; ARTICLE; BURNING MOUTH SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN THRESHOLD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTIOXIDANTS; BURNING MOUTH SYNDROME; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN THRESHOLD; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 58149117954     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2008.01914.x     Document Type: Article

References (29)

1. Ship JA, Grushka M, Lipton JA, Mott AE, Sessle BJ, Dionne RA. Burning mouth syndrome: an update. J Am Dent Assoc. 1995 126 : 842 853.
2. Pedersen AML, Smidt D, Nauntofte B, Christiani CJ, Jerlang BB. Burning mouth syndrome: etiopathogenic mechanisms, symptomatology, diagnosis and therapeutic approaches. Oral Biosci Med. 2004 1 : 3 19.
3. Grushka M, Kawalec J, Epstein JB. Burning mouth syndrome: evolving concepts. Oral Maxillofac Surg Clin North Am. 2000 12 : 287 295.
4. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med. 2003 14 : 275 291.
5. Grushka M, Epstein J, Mott A. An open label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 86 : 557 561.
6. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry. 2002 63 : 38 43.
7. Lamey PJ, Freeman R, Eddie SA, Pankhurst C, Rees T. Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 99 : 48 54.
8. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 103 (Suppl S39 e1 e13.
9. Woda A, Navez ML, Picard P, Gremeau C, Pichard-Leandri E. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 1998 12 : 272 278.
10. Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrasi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 88 : 683 686.
11. Gremeau Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MD et al. Pain. 2004 188 : 51 57.
12. Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol. 1994 77 : 135 140.
13. Zakrzewska JM, Forssell H, Glenny A. Interventions for the treatment of burning mouth syndrome: a systematic review. J Orofac Pain. 2003 17 : 293 300.
14. Femiano F, Gombos F, Scully C. Burning mouth syndrome (BMS): controlled open tríal of the efficacy of alpha-lipoic acid (thioctid acid) on symptomatology. Oral Dis. 2000 6 : 274 277.
15. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha lipoic acid (Thioctic acid) therapy. J Oral Pathol Med. 2002 31 : 267 269.
16. Femiano F, Scully C, Gombos F. Idiopathic dysgeusia: an open trial of alpha lipoic acid (ALA) therapy. Int J Oral Maxillofac Surg. 2002 31 : 625 628.
17. Femiano F, Scully C. Síndrome de boca ardiente. Estudio de la psicoterapia, medicación con ácido alfa-lipoico y combinación de terapias. Med Oral. 2004 9 : 8 13.
18. Femiano F. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha lipoic acid (Thioctic acid) with other therapies. Minerva Stomatol. 2002 51 : 51 57.
19. Femiano F, Gombos F, Scully C. Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol. 2004 18 : 676 678.
20. Zieger D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA et al. Oral treatment with alfa lipoic acid improves symptomatic diabetic polyneuropathy. Diabetes Care. 2006 29 : 2365 2370.
21. Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol. 1992 73 : 570 574.
22. Gorsky M, Silverman S, Chinn H. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients. Oral Surg Oral Med Oral Pathol. 1991 72 : 192 195.
23. Heckmann SM, Heckmann JG, Ungethum A, Hujoel P, Hummel T. Gabapentin has little or no effect in the treatment of burning mouth syndrome results of an open-label pilot study. Eur J Neurol. 2006 13 : 6 7.
24. Petruzzi M, Lauritano D, De Benedittis M, Baldón M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med. 2004 33 : 111 114.
25. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987 31 : 199 209.
26. Svensson P, Kaaber S. General health factors and denture function in patients with burning mouth syndrome and matched control subjects. J Oral Rehabil. 1995 22 : 887 895.
27. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain. 1999 13 : 83 88.
28. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med. 1995 24 : 213 215.
29. Mínguez-Serra MP, Salort-Llorca C, Silvestre-Donat FJ. Pharmacological treatment of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal. 2007 12 : E299 E304.